Drug maker Aurobindo Pharma today said it has received final approval from the US health regulator for Venlafaxine Hydrochloride tablets, used as an anti-depressant.
The company has received the final approval from the US Food & Drug Administration (USFDA) for Venlafaxine Hydrochloride tablets, Aurobindo Pharma said in a filing to the Bombay Stock Exchange (BSE).
The tablets will be launched shortly in strengths of 25 mg, 37.5 mg, 75 mg and 100 mg, the filing added.
Venlafaxine Hydrochloride tablets are used in the treatment of major depressive disorders.
Aurobindo has a total of 114 Abbreviated New Drug Application (ANDA) approvals from the USFDA.
Shares of Aurobindo Pharma today closed at Rs 948.90 on the BSE, down 0.13 per cent from previous close.
